FI942922A - Asetyylisalisyylihappoa sisältävä ihon läpi tapahtuva antojärjestelmä antitromboottiseen terapiaan ja syövän ehkäisyyn - Google Patents

Asetyylisalisyylihappoa sisältävä ihon läpi tapahtuva antojärjestelmä antitromboottiseen terapiaan ja syövän ehkäisyyn Download PDF

Info

Publication number
FI942922A
FI942922A FI942922A FI942922A FI942922A FI 942922 A FI942922 A FI 942922A FI 942922 A FI942922 A FI 942922A FI 942922 A FI942922 A FI 942922A FI 942922 A FI942922 A FI 942922A
Authority
FI
Finland
Prior art keywords
acetylsalicylic acid
delivery system
transdermal delivery
antithrombotic therapy
cancer prevention
Prior art date
Application number
FI942922A
Other languages
English (en)
Swedish (sv)
Other versions
FI113838B (fi
FI942922A0 (fi
Inventor
Frank Becher
Thomas Kissel
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of FI942922A publication Critical patent/FI942922A/fi
Publication of FI942922A0 publication Critical patent/FI942922A0/fi
Application granted granted Critical
Publication of FI113838B publication Critical patent/FI113838B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
FI942922A 1991-12-20 1994-06-17 Menetelmä asetyylisalisyylihapon ihon läpi tapahtuvan antojärjestelmän valmistamiseksi FI113838B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4142483 1991-12-20
DE4142483 1991-12-20
EP9202914 1992-12-16
PCT/EP1992/002914 WO1993012799A1 (de) 1991-12-20 1992-12-16 Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe

Publications (3)

Publication Number Publication Date
FI942922A true FI942922A (fi) 1994-06-17
FI942922A0 FI942922A0 (fi) 1994-06-17
FI113838B FI113838B (fi) 2004-06-30

Family

ID=6447817

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942922A FI113838B (fi) 1991-12-20 1994-06-17 Menetelmä asetyylisalisyylihapon ihon läpi tapahtuvan antojärjestelmän valmistamiseksi

Country Status (23)

Country Link
US (2) US6264978B1 (fi)
EP (1) EP0617623B1 (fi)
JP (1) JP3748270B2 (fi)
KR (2) KR100267442B1 (fi)
AT (1) ATE217528T1 (fi)
AU (1) AU667067B2 (fi)
CA (1) CA2125662C (fi)
CZ (1) CZ285190B6 (fi)
DE (2) DE4241128C2 (fi)
DK (1) DK0617623T3 (fi)
ES (1) ES2176197T3 (fi)
FI (1) FI113838B (fi)
HR (1) HRP921157A2 (fi)
HU (1) HU221679B1 (fi)
IL (1) IL103917A (fi)
NO (1) NO306599B1 (fi)
NZ (1) NZ246158A (fi)
PT (1) PT617623E (fi)
SI (1) SI9200312A (fi)
SK (1) SK67094A3 (fi)
WO (1) WO1993012799A1 (fi)
YU (1) YU75093A (fi)
ZA (1) ZA922814B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240917A (en) * 1991-04-03 1993-08-31 Keimowitz Rudolph M Suppression of thromboxane levels by percutaneous administration of aspirin
WO1994013302A1 (de) * 1991-12-20 1994-06-23 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe
US6071896A (en) * 1992-06-16 2000-06-06 Gundersen Clinic, Ltd. Suppression of thromboxane levels by percutaneous administration of aspirin
EP0671916A1 (de) * 1992-12-07 1995-09-20 LTS Lohmann Therapie-Systeme GmbH & Co. KG Ein acetylsalicylsäure enthaltendes transdermales verabreichungssystem für die antithrombotische therapie und die krebsprophylaxe
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung
DE4429663C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Hydrolyseschutz
WO1997004757A1 (en) * 1995-07-27 1997-02-13 Cal International Limited Transdermal nitrate formulation
AU6709096A (en) * 1995-07-27 1997-02-26 Cal International Limited Pharmaceutical preparation for percutaneous absorbtion
GB2319473A (en) * 1995-07-27 1998-05-27 Cal Int Ltd Transdemal patch containing aspirin
ES2250983T3 (es) * 1995-12-26 2006-04-16 Teikoku Seiyaku Kabushiki Kaisha Utilizacion del acido acetilsalicilico en la fabricacion de un medicamento para el tratamiento de las lesiones de la piel.
DE19601487C2 (de) * 1996-01-17 2001-09-13 Micronas Gmbh Vorrichtung zum Behandeln von malignen Gewebsveränderungen
JPH1112177A (ja) * 1997-06-25 1999-01-19 Teikoku Seiyaku Co Ltd 安定なアスピリン含有外用製剤
DE19949252B4 (de) * 1999-10-13 2004-02-12 Lts Lohmann Therapie-Systeme Ag Verwendung eines superfiziellen therapeutischen Systems zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen und Verfahren zu seiner Herstellung
JP2001187739A (ja) * 1999-12-28 2001-07-10 Teikoku Seiyaku Co Ltd アレルギー性皮膚疾患治療用外用剤
WO2003018023A1 (en) * 2001-08-23 2003-03-06 Bruce Frome Compositions and methods for targeting cerebral circulation and treatment of headache
US20040248858A1 (en) * 2003-06-09 2004-12-09 Parghi Kaumil H. Cure for cancer
US20060127463A1 (en) * 2004-12-15 2006-06-15 Nugara Peter N Composite structure including a low vinyl acetate layer
US20060188558A1 (en) * 2005-02-18 2006-08-24 Mylan Technologies, Inc. Transdermal systems having control delivery system
EP2610242A1 (en) 2006-07-09 2013-07-03 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aspirin
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
CN101688370A (zh) * 2007-05-09 2010-03-31 巴科曼实验室国际公司 用于纸或纸板的烯基琥珀酸酐施胶乳液
CN101687792B (zh) * 2007-06-04 2016-03-02 于崇曦 具有快速皮肤和生物膜穿透速度的非甾体抗炎药的前药及其医药用途
RU2630577C2 (ru) 2008-12-04 2017-09-11 Чунси ЮЙ Композиции интенсивного проникновения и их применение
WO2011076401A1 (de) 2009-12-23 2011-06-30 Holger Schankin Acetylsalicylsäure-haltige, im wesentlichen wasserfreie pharmazeutische zusammensetzungen
AU2013262320B2 (en) 2012-05-16 2018-02-22 Techfields Pharma Co., Ltd. High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
FR2297612A1 (fr) 1975-01-20 1976-08-13 Moorleghem Guy Van Procede de fabrication d'un produit analgesique a usage externe
US4012508A (en) 1975-02-03 1977-03-15 Burton Verna M Topical composition and method
US4219548A (en) 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
FR2496459A1 (fr) 1980-12-19 1982-06-25 Astier Laboratoires Docteur P Composition pharmaceutique sous forme d'un gel contenant de l'acide acetylsalicylique
US4460368A (en) * 1981-10-29 1984-07-17 Almedco, Inc. Trans-dermal medication system
IL68965A (en) 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
US4640689A (en) * 1983-08-18 1987-02-03 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
EP0162239B1 (en) 1984-04-23 1991-08-07 Kao Corporation Percutaneous absorption accelerator and preparation containing same
JPS61167615A (ja) 1985-01-18 1986-07-29 Teisan Seiyaku Kk 薬剤投与方法
US4810699A (en) 1987-02-20 1989-03-07 American Home Products Corporation Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them
JPH01203336A (ja) 1988-02-09 1989-08-16 Teikoku Seiyaku Kk 経皮・口腔粘膜適用製剤
JPH01242521A (ja) 1988-03-23 1989-09-27 Nikko Kemikaruzu Kk 経皮吸収性を高めた消炎鎮痛薬組成物
US4975269A (en) 1989-07-31 1990-12-04 Leonard Chavkin Shelf stable aspirin solutions
WO1992020343A1 (en) 1991-04-03 1992-11-26 Gunderson Medical Foundation, Ltd. Suppression of thromboxane levels by percutaneous administration of aspirin

Also Published As

Publication number Publication date
US5861170A (en) 1999-01-19
CZ285190B6 (cs) 1999-06-16
HU9401849D0 (en) 1994-09-28
HUT74559A (en) 1997-01-28
CA2125662C (en) 2006-10-17
PT617623E (pt) 2002-10-31
ZA922814B (en) 1993-06-23
JPH07502521A (ja) 1995-03-16
US6264978B1 (en) 2001-07-24
NO306599B1 (no) 1999-11-29
NO942325L (no) 1994-06-17
CA2125662A1 (en) 1993-07-08
YU75093A (sh) 1997-08-22
NO942325D0 (no) 1994-06-17
ES2176197T3 (es) 2002-12-01
EP0617623B1 (de) 2002-05-15
FI113838B (fi) 2004-06-30
CZ145694A3 (en) 1995-01-18
EP0617623A1 (de) 1994-10-05
JP3748270B2 (ja) 2006-02-22
HRP921157A2 (en) 1994-10-31
HU221679B1 (hu) 2002-12-28
KR100267359B1 (ko) 2000-11-01
DE59209956D1 (de) 2002-06-20
AU667067B2 (en) 1996-03-07
NZ246158A (en) 1995-10-26
DK0617623T3 (da) 2002-09-09
WO1993012799A1 (de) 1993-07-08
DE4241128C2 (de) 1996-05-23
SI9200312A (en) 1993-06-30
KR100267442B1 (ko) 2000-11-01
KR950703972A (ko) 1995-11-17
DE4241128A1 (en) 1993-06-24
ATE217528T1 (de) 2002-06-15
IL103917A (en) 1996-09-12
IL103917A0 (en) 1993-04-04
SK67094A3 (en) 1995-03-08
FI942922A0 (fi) 1994-06-17
AU3158993A (en) 1993-07-28

Similar Documents

Publication Publication Date Title
FI942922A (fi) Asetyylisalisyylihappoa sisältävä ihon läpi tapahtuva antojärjestelmä antitromboottiseen terapiaan ja syövän ehkäisyyn
ES2067939T3 (es) Sistema de distribucion de un medicamento iontoforetico con un perfil de reparto de dos etapas.
EP0368253A3 (en) Delivery system for pharmaceutical or therapeutic actives
KR950703383A (ko) 초음파 경피약제전달 시스템(ultrasonic transdermal drug delivery system)
AU8933391A (en) Medical drug formulation and delivery system
ATE361093T1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
NO306377B1 (no) Doseform for avgivelse av et medikament
HK1003980A1 (en) Dosage form for dispensing drug and human therapy
NO923859L (no) Medikament
AU5765498A (en) Transdermal therapeutic system for the delivery of hormones
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
CA2231176A1 (en) Long active composition for rectal administration
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
AU3401093A (en) Therapeutic agent for threatened abortion
CA2331414A1 (en) Transdermal therapeutic system for the administration of candesartan
ITMI911950A0 (it) Sistema terapeutico transdermale per la somministrazione di farmaci ad attivita' broncodilatante
FI952805A0 (fi) Asetosalisyylihappoa sisältävä transdermaalinen vapautumisjärjestelmä antitromboottiseen terapiaan ja syövän ennaltaehkäisyyn
NO308195B1 (no) Anvendelse av benzydamin til fremstilling av et legemiddel ved behandling av patologiske tilstander forÕrsaket av TNF
AU4015097A (en) Transdermal therapeutic system having an active compound combination comprising oestriol
EP1264601A3 (en) Treatment of a coronary condition by delivery of therapeutics to the pericardial space
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi
UA29005A (uk) Спосіб лікування трофічних виразок нижніх кінцівок
DK493887A (da) Buccal formulering